247 related articles for article (PubMed ID: 17668048)
1. p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion.
Singh K; Mogare D; Giridharagopalan RO; Gogiraju R; Pande G; Chattopadhyay S
PLoS One; 2007 Aug; 2(7):e660. PubMed ID: 17668048
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor SMAR1 downregulates Cytokeratin 8 expression by displacing p53 from its cognate site.
Pavithra L; Singh S; Sreenath K; Chattopadhyay S
Int J Biochem Cell Biol; 2009 Apr; 41(4):862-71. PubMed ID: 18822384
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.
Rampalli S; Pavithra L; Bhatt A; Kundu TK; Chattopadhyay S
Mol Cell Biol; 2005 Oct; 25(19):8415-29. PubMed ID: 16166625
[TBL] [Abstract][Full Text] [Related]
4. Chromatin remodelling protein SMAR1 inhibits p53 dependent transactivation by regulating acetyl transferase p300.
Sinha S; Malonia SK; Mittal SP; Mathai J; Pal JK; Chattopadhyay S
Int J Biochem Cell Biol; 2012 Jan; 44(1):46-52. PubMed ID: 22074660
[TBL] [Abstract][Full Text] [Related]
5. Chromatin remodeling protein SMAR1 regulates NF-κB dependent Interleukin-8 transcription in breast cancer.
Malonia SK; Yadav B; Sinha S; Lazennec G; Chattopadhyay S
Int J Biochem Cell Biol; 2014 Oct; 55():220-6. PubMed ID: 25239884
[TBL] [Abstract][Full Text] [Related]
6. SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription.
Pavithra L; Mukherjee S; Sreenath K; Kar S; Sakaguchi K; Roy S; Chattopadhyay S
J Mol Biol; 2009 May; 388(4):691-702. PubMed ID: 19303885
[TBL] [Abstract][Full Text] [Related]
7. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
8. Tumor Necrosis Factor alpha (TNFalpha) regulates CD40 expression through SMAR1 phosphorylation.
Singh K; Sinha S; Malonia SK; Chattopadhyay S
Biochem Biophys Res Commun; 2010 Jan; 391(2):1255-61. PubMed ID: 20006573
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of epithelial to mesenchymal transition by E-cadherin up-regulation via repression of slug transcription and inhibition of E-cadherin degradation: dual role of scaffold/matrix attachment region-binding protein 1 (SMAR1) in breast cancer cells.
Adhikary A; Chakraborty S; Mazumdar M; Ghosh S; Mukherjee S; Manna A; Mohanty S; Nakka KK; Joshi S; De A; Chattopadhyay S; Sa G; Das T
J Biol Chem; 2014 Sep; 289(37):25431-44. PubMed ID: 25086032
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor SMAR1 activates and stabilizes p53 through its arginine-serine-rich motif.
Jalota A; Singh K; Pavithra L; Kaul-Ghanekar R; Jameel S; Chattopadhyay S
J Biol Chem; 2005 Apr; 280(16):16019-29. PubMed ID: 15701641
[TBL] [Abstract][Full Text] [Related]
11. Coordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MAR element.
Sinha S; Malonia SK; Mittal SP; Singh K; Kadreppa S; Kamat R; Mukhopadhyaya R; Pal JK; Chattopadhyay S
EMBO J; 2010 Feb; 29(4):830-42. PubMed ID: 20075864
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor SMAR1 represses IkappaBalpha expression and inhibits p65 transactivation through matrix attachment regions.
Singh K; Sinha S; Malonia SK; Bist P; Tergaonkar V; Chattopadhyay S
J Biol Chem; 2009 Jan; 284(2):1267-78. PubMed ID: 18981184
[TBL] [Abstract][Full Text] [Related]
13. Cdc20 directs proteasome-mediated degradation of the tumor suppressor SMAR1 in higher grades of cancer through the anaphase promoting complex.
Paul D; Ghorai S; Dinesh US; Shetty P; Chattopadhyay S; Santra MK
Cell Death Dis; 2017 Jun; 8(6):e2882. PubMed ID: 28617439
[TBL] [Abstract][Full Text] [Related]
14. Direct interaction with and activation of p53 by SMAR1 retards cell-cycle progression at G2/M phase and delays tumor growth in mice.
Kaul R; Mukherjee S; Ahmed F; Bhat MK; Chhipa R; Galande S; Chattopadhyay S
Int J Cancer; 2003 Feb; 103(5):606-15. PubMed ID: 12494467
[TBL] [Abstract][Full Text] [Related]
15. Wild-type p53 inhibits pro-invasive properties of TGF-β3 in breast cancer, in part through regulation of EPHB2, a new TGF-β target gene.
Lam S; Wiercinska E; Teunisse AF; Lodder K; ten Dijke P; Jochemsen AG
Breast Cancer Res Treat; 2014 Nov; 148(1):7-18. PubMed ID: 25257729
[TBL] [Abstract][Full Text] [Related]
16. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of SMAR1 Enhances Radiosensitivity in Human Breast Cancer Cell Line MCF7 via Activation of p53 Signaling Pathway.
Liu HC; Ma F; Shen Y; Hu YQ; Pan S
Oncol Res; 2014; 22(5-6):293-300. PubMed ID: 26629941
[TBL] [Abstract][Full Text] [Related]
18. B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells.
Mannefeld M; Klassen E; Gaubatz S
Cancer Res; 2009 May; 69(9):4073-80. PubMed ID: 19383908
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer amplified sequence 2, a novel negative regulator of the p53 tumor suppressor.
Kuo PC; Tsao YP; Chang HW; Chen PH; Huang CW; Lin ST; Weng YT; Tsai TC; Shieh SY; Chen SL
Cancer Res; 2009 Dec; 69(23):8877-85. PubMed ID: 19903847
[TBL] [Abstract][Full Text] [Related]
20. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
